Found 1314 clinical trials
Valacyclovir for Mild Cognitive Impairment (VALMCI)
mild cognitive impairment (MCI) patients (eMCI and lMCI). The trial will directly address the long-standing viral etiology hypothesis of Alzheimer's disease (AD) which posits that viruses, particularly
- 47 views
- 08 Sep, 2022
- 1 location
Cognitive Fitness for Depression in Older Adults
This research is being done to determine if computerized administered cognitive fitness activities will improve thinking and depression in older depressed adults who are being treated with antidepressants. The investigators are also interested in whether participating in the treatment will result in changes to brain activity measured with magnetic resonance …
- 85 views
- 22 Jan, 2022
- 1 location
Protective Role of Pre-/ Post-biotics on Gut Inflammation, Dysbiosis, and Life Quality in Rett Syndrome (Biotics_RTT) (Biotics_RTT)
The study will examine the potential efficacy and safety of two pre- and post-biotics on markers for gut inflammation and intestinal microbiota ecology in patients with Rett syndrome. Moreover, this trial will search for possible effects on epileptogenesis and quality of life.
- 2 views
- 11 Jul, 2022
- 1 location
AGITATION ASSOCIATED WITH DEMENTIA OF THE ALZHEIMER’S TYPE
A PERSON WITH ALZHEIMER'S MAY FEEL ANXIOUS OR AGITATED. HE OR SHE MAY BECOME RESTLESS, CAUSING A NEED TO MOVE AROUND OR PACE, OR BECOME UPSET IN CERTAIN PLACES.
- 29 views
- 08 Dec, 2020
- 1 location
GAIN: GingipAIN Inhibitor for Treatment of Alzheimer's Disease
GAIN is a clinical trial evaluating whether an investigational drug is safe and can stop the progression of Alzheimer’s Disease by reducing bacterial damage in the brain. The P
- 153 views
- 08 Dec, 2020
- 1 location
NICE-AD (Neurostimulation for Cognitive Enhancement in Alzheimer’s Disease)
The NICE-AD study is a home-based clinical trial examining a treatment for Alzheimer’s Disease. We are interested in examining the effects of the device on cognition, mood, and neuroplasticity
- 32 views
- 02 Nov, 2021
- 1 location
Vielight Neuro RX Gamma Photobiomodulation Device for Moderate to Severe Alzheimer's Disease
quality of life in patients with moderate to severe Alzheimer's Disease. Treatment will occur at home-based treatment sessions with the device.A potential participant will undergo
- 70 views
- 30 Jul, 2021
- 9 locations
Cognitive Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease
Cognitive Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease
- 881 views
- 23 Nov, 2020
- 3 locations
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED, PARALLEL-GROUP, 52-WEEK STUDY EVALUATING THE SAFETY AND EFFICACY OF SIMUFILAM 100 MG TABLETS IN SUBJECTS WITH MILD TO MODERATE ALZHEIMER’S DISEASE
Simufilam is an experimental treatment, meaning that it has not yet been approved by the United States (US) Food and Drug Administration (FDA). In this study, the study medicine will be compared to a placebo. A placebo is a pill that looks exactly like the study medicine but does not …
- 2 views
- 25 Mar, 2022
- 1 location
BRAIN-SILK SIMS.
This study is looking for people who are over 75, are in hospice care, and have Alzheimer’s (or normal cognition, for a comparison). The study is developing a new brain scan for Alzheimer’s.
- 0 views
- 15 Sep, 2020
- 1 location